Clinical Trials Logo
  1. Home
  2. Esophageal Cancer
  3. NCT05617352
  4. Details
NCT05617352 Clinical Trial

The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study

Esophageal Cancer Clinical Trial

Official title:
The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: A Single Center Retrospective Analysis

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05617352
Other study ID # SCCH-TS2204
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 1, 2022
Est. completion date October 10, 2022

Study information
Verified date November 2022
Source Sichuan Cancer Hospital and Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To clarify the effect of Two-field or Three-field Lymphadenectomy on the survival of esophageal squamous cell carcinoma.

Recruitment information / eligibility
Status Completed
Enrollment 1659
Est. completion date October 10, 2022
Est. primary completion date October 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - 1. Men and women aged 18-85 years - 2. Histologically confirmed primary thoracic esophageal squamous cell carcinoma, - 3. Staging PT1b-4A, N0-3, M0 AJCC eighth edition - 4. Excluding lymph node dissection < 15, (meeting the guideline criteria) - 5. The tumor located in the lower middle thoracic. Exclusion Criteria: - 1. Patients with a history of previous thoracic and abdominal surgery that may affect lymphatic reflux - 2. Patients with distant metastasis confirmed by imaging - 3. Patients with obvious surgical contraindications.

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Since the data were collected retrospectively, there were no interventions
Since the data were collected retrospectively, there were no interventions

Locations
Country Name City State
China Sichuan Cancer Hospital Chendu Sichuan

Sponsors (1)
Lead Sponsor Collaborator
Yongtao Han

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary The number of lymph nodes Surgical data were retrospectively collected 2010.1.1-2017.12.30
See also
  Status Clinical Trial Phase
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Terminated NCT01624090 - Mithramycin for Lung, Esophagus, and Other Chest Cancers Phase 2
Recruiting NCT05787522 - Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
Not yet recruiting NCT05542680 - Study on the Design and Application of Special Semi Recumbent Cushion for Postoperative Patients With Esophageal Cancer N/A
Completed NCT03384511 - The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. Phase 4
Completed NCT00003864 - Docetaxel Plus Carboplatin in Treating Patients With Advanced Cancer of the Esophagus Phase 2
Recruiting NCT05491616 - Nivolumab During Active Surveillance After Neoadjuvant Chemoradiation for Esophageal Cancer: SANO-3 Study Phase 2
Active, not recruiting NCT04383210 - Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Phase 2
Completed NCT00199849 - NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine Phase 1
Completed NCT03756597 - PAN-study: Pan-Cancer Early Detection Study (PAN)
Completed NCT00400114 - Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer Phase 2
Completed NCT03652077 - A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies Phase 1
Recruiting NCT04615806 - The Value of Lymph Node Dissection of Indocyanine Green-guided Near-infrared Fluorescent Imaging in Esophagectomy N/A
Active, not recruiting NCT04566367 - Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer N/A
Active, not recruiting NCT03962179 - Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent) N/A
Terminated NCT01446874 - Prevention of Post-operative Pneumonia (POPP) Phase 2/Phase 3
Completed NCT03468634 - Raman Probe for In-vivo Diagnostics (During Oesophageal) Endoscopy N/A
Active, not recruiting NCT02869217 - Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors Phase 1
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A
Recruiting NCT02544737 - Apatinib for Metastatic Esophageal Cancer. Phase 2